Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological Warfare: Implications for Antimicrobial Use.

Ethan Rubinstein1, Itzhak Levi

  • 1The Infectious Diseases Unit, Sheba Medical Center, Tel-Aviv University School of Medicine, Tel Hashomer 52621, Israel.

Current Infectious Disease Reports
|February 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response of Symptomatic Persistent Chronic Disseminated Candidiasis to Corticosteroid Therapy in Immunosuppressed Pediatric Patients: Case Study and Review of the Literature.

The Pediatric infectious disease journal·2017
Same author

Alternative pre-approved and novel therapies for the treatment of anthrax.

BMC infectious diseases·2016
Same author

In vitro evaluation of the effect of linezolid and levofloxacin on Bacillus anthracis toxin production, spore formation and cell growth.

The Journal of antimicrobial chemotherapy·2016
Same author

Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.

Drugs·2015
Same author

Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2014
Same author

Vancomycin revisited - 60 years later.

Frontiers in public health·2014
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
See all related articles

Biological warfare using bacteria like Bacillus anthracis could trigger a "postantibiotic era." Mass antibiotic use poses risks including drug resistance and ecological damage.

Area of Science:

  • Microbiology
  • Public Health
  • Biosecurity

Background:

  • Biological warfare aims to cause widespread incapacitation and social chaos through epidemic-level disease.
  • Specific bacterial agents like Bacillus anthracis and Yersinia pestis are potential bioweapons requiring antibiotic treatment.

Purpose of the Study:

  • To analyze the potential impact of biological warfare on antibiotic availability and the risk of a postantibiotic era.
  • To highlight the challenges associated with mass antibiotic therapy in a biowarfare scenario.

Main Methods:

  • Literature review and analysis of potential bioweapons and their treatment implications.
  • Assessment of logistical, ecological, and resistance-related challenges of mass antibiotic distribution.

Related Experiment Videos

Main Results:

  • Biological attacks necessitate large-scale antibiotic therapy, straining resources.
  • Mass antibiotic use raises concerns about drug resistance, side effects, and ecological disruption.

Conclusions:

  • Biological warfare presents an apocalyptic scenario, potentially accelerating the arrival of a postantibiotic era.
  • Careful consideration of antibiotic stewardship and biosecurity measures is crucial to mitigate these risks.